303A COLLEGE ROAD EAST, PRINCETON, NJ
Company to Speed Up Availability of PDS0101 for HPV16-Positive Cancer
PDS Biotech Achieves Extended Survival in Head and Neck Cancer Trial
Investor Presentation
Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update
Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
News, Material Contracts
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Correspondence
Submission Upload